Hartmuth B. Bittner

The paper presents a brief review on how some concepts on the organism general adaptational reactions developed, including their role…

Attempts to create an artificial heart were highlighted by our journal one year ago. Now we can say that there…

Deciding to discuss the above topic is determined due to a number of reasons. Firstly, the currently used ablation techniques…

A review and a critical analysis of the specialized literature on justification for the measurement equation and an estimation of…

Hartmuth B. Bittner

Recipients of ventricular assist devices (VADR) have a higher incidence to develop antibodies (Abs) against human leukocyte antigens (HLA). Non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are also implicated in the pathogenesis of acute rejection and allograft vasculopathy. We monitored non-HLA- and HLA-Abs in VADR up to one year after implantation.

Cardiac allograft vasculopathy (CAV) accounts for major morbidity and mortality late in the heart transplant (HTx) history. The role of antibodies (Abs) directed against human leukocyte antigens (HLA) and non-HLA antigens in the pathogenesis of CAV are still under investigation.

UPCOMING ISSUE

Our book in WoS™ Core Collection

We are glad to inform you that the book "Theoretical principles of heart cycle phase analysis" written by researchers from Russian New University has been accepted and indexed in The Book Citation Index in Web of Science™ Core Collection

VIDEO ABOUT CARDIOMETRY

OUR PARTNERS

Russian New University


Your online partner for English language editing, proofreading, medical writing, formatting, design & development and publication support services